Pakistan approaches Indian firm to buy vaccine against XDR typhoid

  • Pakistani health authorities have approached an Indian vaccine manufacturer, Bharat Biotech International Limited, for the supply of typhoid conjugate vaccine to contain the Extensively Drug Resistant (XDR) typhoid, which has claimed over a dozen lives in Sindh alone and has become highly endemic in the province, especially in Karachi
  • Bharat Biotech International Limited is the only manufacturer of the typhoid conjugate vaccine that is sold under the brand name “Typbar TCV” and it is the world’s first clinically proven conjugate typhoid vaccine.
  • “The federal government has approached the Indian vaccine manufacturer through the GAVI Alliance to provide us the typhoid conjugate vaccine, which is the only vaccine prequalified by the World Health Organisation (WHO) to prevent XDR typhoid,” Sindh Health Minister Dr Azra Pechuho told journalists in Karachi